Opportunity Information: Apply for GH GHS 09 003
Apply for GH GHS 09 003
- The Office of the Assistant Secretary for Health in the health sector is offering a public funding opportunity titled "FY09 Strengthen National Immunization Programs and Regional Networks in the Latin America and Caribbean Region" and is now available to receive applicants.
- This funding opportunity was created on Sep 8, 2009 and posted on Sep 8, 2009.
- Applicants must submit their applications by Sep 19, 2009 Refer to the grant announcement regarding application submission requirements, dates and times.. (Agency may still review applications by suitable applicants for the remaining/unused allocated funding in 2026.)
- Each selected applicant is eligible to receive up to $1,224,065.00 in funding.
- The number of recipients for this funding is limited to 1 candidate(s).
- Eligible applicants include: Others (see text field entitled Additional Information on Eligibility for clarification).
- Assistance will be provided only to the PAHO Secretariat for this project and HHS solicits no other applications. PAHO is the most appropriate and qualified agency to conduct the activities under this cooperative agreement for the following reasons 1. Access to all the countries in the LAC region 2. Extensive experience in the improvement of health in the LAC region 3. Success as a leader in public health in general and in immunization in specific in the LAC region 4. The implementation of this project by PAHO is in the best interests of the U.S. Government by enabling the leverage of other government investments
[Watch] Creating a grant proposal using the step-by-step wizard inside the applicant portal:
Opportunity Summary:
The FY09 Strengthen National Immunization Programs and Regional Networks in the Latin America and Caribbean (LAC) Region opportunity was a U.S. Department of Health and Human Services cooperative agreement designed to reinforce how countries in Latin America and the Caribbean prevent, detect, and respond to vaccine-preventable diseases. The central aim was to strengthen national immunization programs and the regional systems that connect them, with a practical focus on better disease surveillance, stronger routine vaccination delivery, and improved decision-making around the rollout and monitoring of newer or underused vaccines. A major theme running through the announcement is coordination: activities were expected to align with other resources and ongoing initiatives in each country to avoid duplicating work and to build on what already exists.
The project laid out three main technical priorities. First, it intended to support surveillance for vaccine-preventable diseases across the region while also improving routine immunization delivery systems. In practice, this points to investments in the foundational components that keep immunization programs effective: timely detection and reporting of cases, stronger monitoring of coverage, and the operational pieces that help services reach people consistently. Second, it aimed to build the capacity of the Pan American Health Organization (PAHO) and Ministries of Health to access and use critical information when deciding whether to introduce new vaccines and how to track implementation once introduced. That emphasis reflects a need for stronger evidence-based policy and program management, such as evaluating disease burden, understanding cost and impact considerations, and monitoring uptake and performance after a vaccine is added or scaled up. Third, it sought to improve health systems in underserved communities by increasing access to immunization services and by promoting collaborations that support surveillance and immunization programming, including building national capacity to monitor vaccine adverse events. The adverse event component is important because public trust and safe program expansion depend on the ability to detect, investigate, and respond to safety signals, and to do so in a way that is coordinated between immunization programs and regulatory authorities.
The announcement also highlights how implementation should connect with established regional efforts rather than starting from scratch. It specifically references existing vaccine adverse event surveillance networks, such as SANEVA, noting that these networks include representatives from National Immunization Programs and National Regulatory Agencies. The inclusion of SANEVA signals that the work was expected to integrate technical expertise already present in the region, improve consistency across countries, and strengthen cross-border learning and standardized practices for vaccine safety surveillance.
From a funding and administrative standpoint, this was a discretionary health grant using the cooperative agreement mechanism, meaning the U.S. government anticipated substantial involvement and collaboration during implementation rather than a hands-off pass-through award. The opportunity anticipated a single award, with an estimated funding range between $956,945 (floor) and $1,224,065 (ceiling), and it did not require cost sharing or matching funds. The posting date was September 8, 2009, and the closing date was September 19, 2009, with the opportunity archived on October 19, 2009.
Eligibility was tightly restricted: assistance was to be provided only to the PAHO Secretariat, and no other applications were solicited. The justification given was that PAHO was uniquely positioned to deliver the project because it has access across all countries in the LAC region, extensive experience improving health in the region, a strong track record of leadership in immunization, and the ability to leverage other investments in a way that aligns with U.S. government interests. The sponsoring agency listed was the Office of the Assistant Secretary for Health. For technical access issues, the notice directed applicants to the Grants.gov help desk, though in practical terms PAHO was the only eligible applicant for this award.
FAQs: FY09 Strengthen National Immunization Programs and Regional Networks in the Latin America and Caribbean (LAC) Region
What is this funding opportunity?
This was an FY09 U.S. Department of Health and Human Services cooperative agreement focused on strengthening national immunization programs and the regional networks that connect them across Latin America and the Caribbean (LAC), with an emphasis on vaccine-preventable disease prevention, detection, and response.
What was the main goal of the project?
The central aim was to reinforce how countries in the LAC region prevent, detect, and respond to vaccine-preventable diseases by strengthening routine immunization delivery systems, improving disease surveillance, and improving decision-making around the rollout and monitoring of newer or underused vaccines.
What were the three main technical priorities?
The project described three main technical priorities:
- Support surveillance for vaccine-preventable diseases across the region while also improving routine immunization delivery systems.
- Build the capacity of the Pan American Health Organization (PAHO) and Ministries of Health to access and use critical information to decide whether to introduce new vaccines and how to monitor implementation once introduced.
- Improve health systems in underserved communities by increasing access to immunization services and promoting collaborations that support surveillance and immunization programming, including building national capacity to monitor vaccine adverse events.
What kinds of activities did the surveillance and routine immunization priority imply?
Based on the announcement, this priority pointed toward strengthening foundational components of immunization programs, such as timely detection and reporting of cases, stronger monitoring of immunization coverage, and operational improvements that help routine services reach people consistently.
How did the opportunity address new or underused vaccines?
It emphasized improving evidence-based decision-making for introducing newer or underused vaccines and monitoring them after introduction, including strengthening access to and use of critical information needed for policy and program management.
What did the opportunity say about monitoring vaccine implementation after introduction?
It highlighted the need to track implementation once vaccines are introduced, which includes monitoring uptake and performance after a vaccine is added or scaled up.
Why was vaccine adverse event monitoring included?
The opportunity specifically included building national capacity to monitor vaccine adverse events, reflecting the importance of detecting, investigating, and responding to vaccine safety signals in a coordinated way as immunization programs expand and as trust in immunization systems is maintained.
What role did collaboration and coordination play in the project design?
Coordination was a major theme. Activities were expected to align with other resources and ongoing initiatives in each country to avoid duplicating work and to build on existing efforts rather than starting from scratch.
Did the opportunity reference any existing regional vaccine safety surveillance networks?
Yes. It referenced existing vaccine adverse event surveillance networks such as SANEVA and noted that these networks include representatives from National Immunization Programs and National Regulatory Agencies.
What was the intended benefit of connecting with networks like SANEVA?
By integrating with established networks, the work was expected to leverage existing technical expertise in the region, improve consistency across countries, and strengthen cross-border learning and standardized practices for vaccine safety surveillance.
What funding mechanism was used?
This was a discretionary health grant using the cooperative agreement mechanism, which indicates substantial U.S. government involvement and collaboration during implementation rather than a hands-off, pass-through award.
How many awards were anticipated?
The opportunity anticipated a single award.
What was the estimated funding range?
The estimated funding range was $956,945 (floor) to $1,224,065 (ceiling).
Was cost sharing or matching required?
No. The opportunity did not require cost sharing or matching funds.
Who was eligible to apply?
Eligibility was restricted to the PAHO Secretariat. No other applications were solicited.
Why was eligibility limited to PAHO?
The announcement stated that PAHO was uniquely positioned due to its access across all countries in the LAC region, extensive experience improving health in the region, leadership in immunization, and ability to leverage other investments in a way that aligns with U.S. government interests.
Which U.S. government office sponsored the opportunity?
The sponsoring agency listed was the Office of the Assistant Secretary for Health.
What were the key dates for the opportunity?
The posting date was September 8, 2009. The closing date was September 19, 2009. The opportunity was archived on October 19, 2009.
Where were applicants directed for technical access issues?
For technical access issues, the notice directed applicants to the Grants.gov help desk.
Could organizations other than PAHO submit an application through Grants.gov?
No. The opportunity stated that assistance was to be provided only to the PAHO Secretariat and that no other applications were solicited, even though technical help resources were referenced.
What region did the project focus on?
The project focused on countries in Latin America and the Caribbean (LAC) and on the regional systems that connect national immunization programs across the region.
What kinds of systems were the project trying to strengthen?
It aimed to strengthen both national immunization programs (including routine vaccination delivery and surveillance) and regional networks and systems that facilitate coordination, shared practices, and information use across countries.
Browse more opportunities from the same category: Health
Next opportunity: Cooperative Ecosystem Studies Unit, South Florida Caribbean CESU
Previous opportunity: Children, Youth Families at Risk Sustainable Community Projects
USGrants.org Applicant Portal:
Are you interested in learning about about how to apply for this government funding opportunity? You can create a free applicant account and receive instant access to our applicant portal that many business owners like you have benefited from.
Apply for GH GHS 09 003
[Watch] how do funding administrators access proposals?
Applicants also applied for:
Applicants who have applied for this opportunity (GH GHS 09 003) also looked into and applied for these:
| Funding Opportunity |
|---|
| Traumatic Brain Injury States Grant Program, Implementation Partnership Grants Apply for HRSA 10 022 Funding Number: HRSA 10 022 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Ryan White Part A HIV Emergency Relief Grant Program Apply for HRSA 10 031 Funding Number: HRSA 10 031 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Strengthening Ugandas Systems for Treating AIDS Nationally Apply for RFA 617 09 000005 Funding Number: RFA 617 09 000005 Agency: Uganda USAID Kampala Category: Health Funding Amount: $75,000,000 |
| Biosignature Discovery for Personalized Treatment in Depression (U01) Apply for RFA MH 10 040 Funding Number: RFA MH 10 040 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Draft PD Water, Sanitation and Hygiene for Comments only Apply for 669 09 107 Funding Number: 669 09 107 Agency: Liberia USAID Monrovia Category: Health Funding Amount: $11,000,000 |
| FY09 Supplement to existing cooperative agreement for flu prevention education project. Apply for HP ATP 09 001 Funding Number: HP ATP 09 001 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $600,000 |
| Ancillary Studies in Clinical Trials of CNS/PNS Disorders NINDS Accelerated Awards Program (R01) Apply for PAR 09 263 Funding Number: PAR 09 263 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| HIV Prevention for At Risk Populations in Russia Apply for USAID RUSSIA OH 09 0004 RFA Funding Number: USAID RUSSIA OH 09 0004 RFA Agency: Russia USAID Moscow Category: Health Funding Amount: $9,500,000 |
| Social and Behavioral Interventions to Increase Organ and Tissue Donation Apply for HRSA 10 037 Funding Number: HRSA 10 037 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Public Education Efforts to Increase Solid Organ Donation Apply for HRSA 10 033 Funding Number: HRSA 10 033 Agency: Health Resources and Services Administration Category: Health Funding Amount: Case Dependent |
| Functional Modeling of Pediatric Upper Airway Disorders (R01) Apply for RFA HL 10 017 Funding Number: RFA HL 10 017 Agency: National Institutes of Health Category: Health Funding Amount: $650,000 |
| Special Diabetes Program for Indians (SDPI) Community Directed Grant Program Apply for HHS 2010 IHS SDPI 0001 Funding Number: HHS 2010 IHS SDPI 0001 Agency: Indian Health Service Category: Health Funding Amount: $6,000,000 |
| 2009 Border Influenza Initiative Apply for GH GHS 09 005 Funding Number: GH GHS 09 005 Agency: Office of the Assistant Secretary for Health Category: Health Funding Amount: $1,222,000 |
| Statewide Family Network Grants Apply for SM 10 003 Funding Number: SM 10 003 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $60,000 |
| Summer Research Training in Aging for Medical Students (T35) Apply for RFA AG 10 007 Funding Number: RFA AG 10 007 Agency: National Institutes of Health Category: Health Funding Amount: $130,000 |
| Statewide Consumer Network Grant Apply for SM 10 004 Funding Number: SM 10 004 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $70,000 |
| Secondary Analyses of Existing Data Sets and Stored Biospecimens to Address Clinical Aging Research Questions (R01) Apply for PA 09 265 Funding Number: PA 09 265 Agency: National Institutes of Health Category: Health Funding Amount: Case Dependent |
| Children s Health Insurance Program Reauthorization Act (CHIPRA) Quality Demonstration Grant Program Apply for HHS 2010 CMS CHIPRA 0002 Funding Number: HHS 2010 CMS CHIPRA 0002 Agency: Centers for Medicare Medicaid Services Category: Health Funding Amount: $5,000,000 |
| Lung Transplantation Planning Grants for Clinical Trials of Novel Therapies (R34) Apply for RFA HL 10 016 Funding Number: RFA HL 10 016 Agency: National Institutes of Health Category: Health Funding Amount: $450,000 |
| Cooperative Agreements for Comprehensive Community Mental Health Services for Children and Their Families Program Apply for SM 10 005 Funding Number: SM 10 005 Agency: Substance Abuse Mental Health Services Adminis. Category: Health Funding Amount: $1,000,000 |
Grant application guides and resources
It is always free to apply for government grants. However the process may be very complex depending on the funding opportunity you are applying for. Let us help you!
Apply for Grants
Premium leads for funding administrators, grant writers, and loan issuers
Thousands of people visit our website for their funding needs every day. When a user creates a grant proposal and files for submission, we pass the information on to funding administrators, grant writers, and government loan issuers.
If you manage government grant programs, provide grant writing services, or issue personal or government loans, we can help you reach your audience.
Subscribe to Leads
Request more information:
Would you like to learn more about this funding opportunity, similar opportunities to "GH GHS 09 003", eligibility, application service, and/or application tips? Submit an inquiry below:
Don't forget to subscribe to our grant alerts mailing list to receive weekly alerts on new and updated grant funding opportunities like this one in your email.